363 related articles for article (PubMed ID: 11641241)
1. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
[TBL] [Abstract][Full Text] [Related]
3. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
4. Tyrp1 and oculocutaneous albinism type 3.
Sarangarajan R; Boissy RE
Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
Svedine S; Wang T; Halaban R; Hebert DN
J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
[TBL] [Abstract][Full Text] [Related]
6. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.
Potterf SB; Furumura M; Sviderskaya EV; Santis C; Bennett DC; Hearing VJ
Exp Cell Res; 1998 Oct; 244(1):319-26. PubMed ID: 9770375
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo.
Kobayashi T; Hearing VJ
J Cell Sci; 2007 Dec; 120(Pt 24):4261-8. PubMed ID: 18042623
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
10. Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin.
Popescu CI; Paduraru C; Dwek RA; Petrescu SM
J Biol Chem; 2005 Apr; 280(14):13833-40. PubMed ID: 15677452
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
Toyofuku K; Wada I; Spritz RA; Hearing VJ
Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
[TBL] [Abstract][Full Text] [Related]
12. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
Ray K; Chaki M; Sengupta M
Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
[TBL] [Abstract][Full Text] [Related]
13. l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation.
Hirobe T; Ishikawa A
J Dermatol Sci; 2015 Dec; 80(3):203-11. PubMed ID: 26475433
[TBL] [Abstract][Full Text] [Related]
14. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine.
Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ
Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
[TBL] [Abstract][Full Text] [Related]
16. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase stabilization by Tyrp1 (the brown locus protein).
Kobayashi T; Imokawa G; Bennett DC; Hearing VJ
J Biol Chem; 1998 Nov; 273(48):31801-5. PubMed ID: 9822646
[TBL] [Abstract][Full Text] [Related]
18. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
[TBL] [Abstract][Full Text] [Related]
19. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2.
Manga P; Boissy RE; Pifko-Hirst S; Zhou BK; Orlow SJ
Exp Eye Res; 2001 Jun; 72(6):695-710. PubMed ID: 11384158
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants.
Dolinska MB; Anderson DE; Sergeev YV
Protein Sci; 2023 Jan; 32(1):e4518. PubMed ID: 36412553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
